Weight Loss Research, Health Insights & Smarter Choices
GLP-1 drugs and asthma-The latest 2026 research provides an encouraging signal for people living with both asthma and obesity. GLP-1 medications are best known for helping with obesity, type 2 diabetes and related metabolic conditions. But researchers are now examining whether these medicines may offer benefits beyond weight loss and blood-sugar control. One of the … Read more
Quitting GLP-1 drugs or a diet can cause weight regain—two strategies could help prevent Millions of Americans are now using GLP-Drugs such as Wegovy and Zepbound to lose weight and improve their health. These medicines can produce significant weight loss. But an important question remains: What happens when treatment stops? Research shows that weight regain … Read more
GLP-1 drugs in 2026: More people without diabetes use drugs for weight loss GLP-1 medicines have changed how doctors approach obesity, type 2 diabetes and several related health problems. Drugs such as Wegovy, Ozempic and other GLP-1-based treatments can reduce appetite, improve blood sugar control and help many people lose significant amounts of weight. But … Read more
New weight-loss drugs 2026 and obesity treatments Originally published May 18, 2026. Updated August 19, 2026, with revised U.S. FDA approval information, clinical-trial developments, references, and FAQs. Introduction The world of weight-loss medicine is changing faster than ever before. A new generation of obesity medications is showing results in clinical trials that could reshape how … Read more
GLP-1 weight-loss drugs can improve physical health and confidence, but experts believe weight loss, changing self-esteem, lifestyle shifts, and personal circumstances together influence relationships as well. Millions of people worldwide are using GLP-1 weight-loss medications such as Mounjaro and Ozempic to lose weight and improve their health. While doctors often discuss common side effects like … Read more
